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Probiotics in Allergic Diseases
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Đorđe Filipović, Tamara Bakic and Zorica Zivkovic
Abstract
Allergic diseases are the most common chronic diseases in children and no 
complete agreement on effective measures for primary prevention is available. 
Atopic family history is one of the most important risk factors for the development 
of asthma. A decline in microbial diversity due to modern lifestyle particularly in 
urban areas was proposed to have an important role in allergic epidemic. Recent 
studies are more focused on the specific mode of prevention such as probiotic usage 
in early pregnancy and infants period. It is well known that the composition of the 
gastrointestinal microbiota has been postulated to play a role in the development of 
allergies because it promotes potentially antiallergenic processes: TH1-type immu-
nity, generation of TGF (which has an essential role in suppression of TH2-induced 
allergic inflammation and induction of oral tolerance), and IgA production, an 
essential component of mucosal immune defenses. Probiotic interventions adminis-
tered during pregnancy and breastfeeding offer a unique opportunity to influence a 
range of important maternal and infant outcomes.
Keywords: allergy, atopic dermatitis, probiotics
1. Introduction
According to the epidemiological data, half of pediatric population will suffer 
from allergic diseases until the end of 2020. With that prevalence of more than 
30%, they represent the most common disorders of children, adolescents, and 
adults [1]. A great increase of the prevalence of allergic diseases globally in the 
last 10 years are best described in a concept of “allergic epidemic” [2]. Germany 
multi-center allergy study is one of the most important epidemiological studies 
on allergic diseases, showing age related manifestation of allergic diseases, best 
described in “allergic march” concept. Allergies start in early infancy as an atopic 
dermatitis or food allergies, followed with the development of respiratory aller-
gies such as allergic rhinitis and/or asthma [3]. Different from all other chronic 
diseases such as diabetes mellitus, hypertension, etc., allergic diseases manifest 
as it has been previously mentioned early in infancy, according to some authors 
even prenatal. It is well known that allergic diseases are multifactorial, so both 
environmental and genetic factors may play an important role in their pathogen-
esis. Identification of prenatal and early postnatal factors is of a great importance 
for early prevention and intervention [4–6]. Due to many phenotypes and geno-
types as well as different patients’ needs although a great availability of pharma-
cological options, treating allergies still represents a great challenge. Detection 
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of individual risk factors and identification of predictive markers are of a great 
importance in primary prevention, early intervention, and immune modulation 
of a natural course of allergic diseases [7]. It is well know that the development 
of immune system starts in 11 gestation week with the production of IgE anti-
bodies. Detection of specific IgE antibodies on inhalatory and nutritive allergens 
is not possible in cord core blood. Except dry skin other clinical manifestation 
of allergies is not presented in infants. Atopic dermatitis will develop in the first 
year of life in a case of a great transdermal water loss between 2nd day of life and 
2nd month of life. As we have already mentioned, both genetic and “in utero” 
environmental factors are responsible for allergy development. Uni or bilateral 
positive family history of allergies, diet habits, obesity, smoking, and drug use 
during pregnancy, season at time of birth as well as gestational age, the way of 
delivery are known to be an very important risk factors. Primary prevention 
and early intervention can prevent the development of atopic march. It includes 
treating skin with emollient creams, breast feeding in the first year of life, pro-
biotics, and vitamin D during pregnancy and during the first year of life, early 
introduction of solid food as well as allergens [8]. Many hypotheses on causes 
of the increase in allergic diseases have been suggested. One of the most inves-
tigated hypotheses is “hygiene hypothesis”, helping us to understand early-life 
events. It is well known that early exposure to common bacterial triggers such as 
endotoxins, LPS, or hemlines might have an allergy preventive effect.
The second worldwide accepted concept of reduced exposure (exposure to small 
amounts of foreign proteins) in exclusively breastfeeding children may rather lead to 
tolerance than to clinical allergic disease. Other routes of exposure via inhalation or 
via the skin cannot be totally avoided; interventional studies on avoidance/reduction 
of indoor allergen exposure (house dust mite and cat) have not shown convincing 
results. EAACI evidence-based recommendation for prevention of food and respira-
tory allergy prevention includes: no special diet during pregnancy or for the lactating 
mother, exclusively breastfeeding for 4–6 months, if needed hypoallergenic formula 
is recommended, avoids exposure to tobacco smoke, and avoids pets at home [9, 10].
2. The role of microbiome
All plants, animals, and humans live in close association with microbial organisms. 
The Human Microbiome Project has showed that the human body contains trillions 
of microorganisms which outnumber human cells by 10 to 1. Their genes encoded 
proteins essential for human survival. The role of microbes is of particular impor-
tance in gastrointestinal tract where they are involved in break down proteins, lipides, 
and carbohydrates in monomers suitable for absorption [11]. They are also involved 
in vitamin synthesis as well as in immuno modulation. Mice raised under germ free 
conditions have suffered from deficit in innate and adaptive immunity suggesting 
that the microbiome may play a crucial role in maturation of child immune system. 
Furthermore, experimental studies in germ free mice showed that those mice devel-
oped easily allergic diseases. Reconstruction of neonate mice with a conventional 
microbic protected the animals from allergic diseases.
The protective role of exposure to a wide diversity of microbial is best described 
in children raised on traditional farms [12]. Those children have a much lower 
prevalence of asthma, have fever, and allergic sensitization in comparison to 
children grown up in urban areas expect those who are exposed to environmental 
microbes (those who keep dogs indoors) [13].
Gut microbiota is one of the most investigated topics in the last couple of 
years. Human microbiota represent a community of commensal, symbiotic, and 
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pathogenic bacteria that live in and on human body with the widest and probably 
most important community in human gut.
3. History of probiotics
Several thousand years ago, ancient Roman scientist Gaius Plinius Secundus 
Maior recommended fermented milk to treat gastrointestinal problems. Benefits 
of probiotics contained in sour milk cream or yogurt are mentioned even in Holy 
Bible. In 1900, Moro isolated the first bacteria that produced lactic acid Bacillus 
acidophilus later called Lactobacillus acidophilus. Ilja Iljic Mecnikov was the first 
scientist who proved benefits of so-called good lactic acid produced bacteria par-
ticularly on gastrointestinal tract. In his hypothesis on autointoxication, he claimed 
that human body is intoxicated with toxins and pathogenic bacteria from food and 
he proposed consumption of lactic acid bacteria contained in Bulgarian yogurt in 
treating this disorder. The bacteria isolated from Bulgarian yogurt later became 
famous under name Lactobacillus delbrueckii strain, substring bulgaricus.
Henri Tiser from Pasteur Institute isolated Bifidobacterium bifidum from the feces 
of health breastfeeding infants and advised that bacteria for treating infants with diar-
rhea. Anri Boulardii French microbiologist discovered and isolated Saccharomyces 
boulardii that was used in South-eastern Asia for thousands of years for treating 
cholera [14]. Lactobacillus rhamnosus GG strain is one of the most investigated bac-
teria strain. IT was discovered by two scientists Sherwood Gorbach and Bari Goldin 
in 1983 [15]. Word probiotic comes from a Greek word pro+bios that means “for life” 
and it is used for the first time in 1953 when Kollath described organic and nonorganic 
food additives that are necessary for treating malnutrition. In 1965, Lilly and Still 
well described probiotics as substances that are produced by one microbe in order to 
stimulate the growth of another microbe contrary to the term antibiotics.
In 2001, World Health Organization (WAO) defined probiotics as live microbes 
that can have a positive effects on wellbeing if they use in a proper way and 
quantities.
In 2002, Food and Agriculture Organization and WHO published recom-
mendation for probiotics in food [16]. In 2014, WHO reviewed probiotic defini-
tion in terms of needs for evidence base clinical efficacy of certain probiotics 
strains. Nowadays, worldwide accepted definition of probiotics is: probiotics are 
live microbes which benefits and positive effects on human health if they use in 
adequate quantities are proven in control clinical studies [17, 18]. Old concept of 
sterile “in utero” development has been abandoned. According to recent studies, 
colonization of fetal gut started in utero predominantly with maternal oral, vaginal, 
and gut microbiota. Neither placenta neither amniotic fluid is sterile; fetus received 
its first dose of probiotics with the ingestion of amniotic fluid [19, 20].
The most relevant prenatal factors for the formation of gut microbiota are maternal 
hygiene, particularly dental, diet, infectious, and antibiotics usage. Perinatal factors are 
also antibiotics during delivery, gestational age, the way of delivery, and medical staff 
in delivery room [21]. Post natal factors include: skin to skin contact, breast feeding, 
pets, baby bathing, as well as other environmental factors. To summarize all those 
maternal as well as placental factors have a key role in the development of a child gut 
microbiota. Moreover, the presence of pathogenic bacteria in amniotic fluid can induce 
a cascade of inflammatory response and prostaglandin synthesis that leads to the 
uterus contraction and preterm delivery. In utero infection particularly chorioamnion-
itis presents key risk factors for preterm delivery.
There is a substantial body of evidence supporting transplacental immune 
regulation during pregnancy. Maternal IgGs loaded with, for example, microbial 
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components from the mother cross the fetal-maternal barrier by an active process 
from 13 weeks gestation [22], conveying temporary passive immunity [23] and 
influencing fetal innate immune development [24]. In contrast, cellular components 
are generally separated by the placenta, with some leakage in both directions with-
out preference toward a specific cell type [25]. This cellular leakage is functionally 
important, as maternal cells residing in fetal lymph nodes induce fetal regulatory 
T cells that suppress antimaternal immunity [26]. Transplacental immune regula-
tion may be further mediated by cytokines and hormones [27], through bacterial 
products such as short-chain fatty acids or lipopolysaccharides (LPS) [28, 29].
Santner-Nanan et al. have demonstrated a strong correlation of peripheral blood 
Treg cells between the mother and the fetus [30]. In contrast, there was no significant 
Treg cell correlation between the father and the fetus, implicating that the specific 
context of pregnancy, that is, the placental environment, rather than haploidentical 
genetic parental similarity to the fetus, is responsible for this correlation. Maternal 
infant alignment in Treg cells appeared to be mediated by IL-10, a pleiotropic cyto-
kine with potent immunoregulatory properties [31]. Treg cells are characterized by 
increased expression of the IL-10 receptor-α (IL-10RA), making them more sensitive 
to the effects of IL-10. The IL-10 regulates Bcl-2 expression in Treg cells, which could 
contribute to Treg cell survival in both the mother and the infant [32].
In the context of alignment between maternal and infant Treg, the evidence that 
has been studied suggesting an association between complicated pregnancy with 
preeclampsia and an increased risk of asthma, as well as allergic offspring sensitiza-
tion [32]. A potential antecedent common to both mother and child is the mother’s 
microbiome and its metabolic products, including short-chain fatty acids (SCFA).
Maternal IgG may play a key role in mediating the association between the 
maternal microbiome and fetal immune development. Of the five immunoglobulin 
classes, maternal IgG is the only antibody that significantly crosses the human 
placenta [22]. The active transport of IgG occurs via the neonatal Fc receptor (FcRn) 
within the syncytiotrophoblast (ST) cells at the surface of the chorionic villi of 
the placenta. Once bound to the FcRn receptor, IgG is packaged in endosomes and 
protected from degradation until it dissociates into the fetal circulation [33, 34].
This materno-fetal IgG transport is an important mechanism that confers 
passive humoral immunity to the fetus, so that after birth, the infant is protected 
against infections while its own immune system develops [22, 28]. Allergen-specific 
maternal IgG also plays a role in the induction of immune tolerance in infant [35]. 
Until recently, maternal IgG transfer during gestation had only been linked to fetal 
humoral immunity, but there is now good evidence that maternal IgG also plays 
a crucial in fetal innate immune development [24]. 61.1% of bacteria isolated in 
meconium of preterm infants (younger than 33 gestational weeks) are those that 
are also isolated from amniotic fluid, the majority of them belong to the three 
strains: Enterobacteria, Enterococcus, Lactobacillus, Photorhabdus, and Tanarella. 
Those bacteria are found to have a negative correlation with gestational age which 
suggests their important role in initiation of preterm delivery [36, 37].
4.  Gestational age is a second important factor in the development of 
infant gut microbiota
Studies have been already proven that certain bacteria in amniotic fluid can 
provoke preterm labor. Preterm babies in comparison to term babies have more 
anaerobe bacteria. This fact can be described with several facts: preterm babies 
are at high risk of postnatal complications such as asphyxia, acute respiratory 
distress development, neonatal sepsis, necrotic enterocolitis, etc. In terms of that 
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they are prescribed more often both oxygen and antibiotics treatment that are 
together increase hospitalization days particularly in NICU – Neonatal Intensive 
Care Unit. Only three bacteria strains are found in preterm babies at 10 days of life: 
Enterobacteria (E. coli and Klebsiella), Enterococcus faecalis and Staphylococcus 
aureus, and haemolyticus. On the other side, colonization with bifidobacteria in 
preterm infants is postponed [38]. The way of delivery is the third factor for gut 
microbiota development. A great number of data suggested that cesarean section 
alongside with the intrapartal antibiotics usage is independent risk factors for gut 
disbiosis. During vaginal delivery, an infant become colonize with maternal vaginial 
bacteria. Grounlad and authors showed that even 6 months after delivery gut of 
infants born on caesarian section contain less bacteria of Bacteroides fragilis strains. 
Finland study has proven more bacteria of Clostridium strain in children born 
on vaginal way in comparison to those born via cesarean section. Lactobacillus, 
Prevotella, and Sneathia strains are predominant in gut microbiota of children 
born vaginal way, while on the other side, Staphylococcus, Corynebacterium and 
Propioni bacterium strains are dominant in another group of children born on 
caesarian session [39]. Postnatal prevention includes at the first place breast feeding 
followed with the onetime introduction of solid food and allergens. Breastfed chil-
dren are proved to have predominantly bifidobacteria strains in their gut microbiota 
while infants fed with formulas had more bacterioides strains. It is well know that 
mothers milk contain special ingredients that can have immuno modulation effects 
on infants immune system. Rutava and authors showed that there is a special 
interaction between gut microbiota and transforming growth factor beta from 
human milk that are most potent antiinflammatory factor of a great importance 
also for maturation of intestinal tract as well as the production of IgA antibodies. 
According to this hypothesis bacteria from uterus have been actively transported 
in breast gland and secrete in human milk and in that way transfer immune toler-
ance to the infants. Moreover, it is proven that if mother use probiotics particularly 
Lactobacillus strain during breast feeding increase the number of bifidobacteria in 
gut of breast-fed infants [40].
Intestinal microbiology of early life has been best described in the first thousand 
days concept (PAI 2014). According to that hypothesis, the first thousand days 
of early life (230 days prenatal and 2 years postnatal) are crucial for establishing 
of symbiosis for the whole life. This is one of the most important mechanisms of 
evolution f as intestinal microbiota is in close relation with etiopathogenesis of 
allergic, autoimmune disease, and tumors [41].
5. Probiotic in prevention of atopic march
The development of allergic diseases is best described in a concept of atopic 
march. Allergies start in early infancy with atopic dermatitis, followed by IgE 
mediated food allergies and asthma development ended up with allergic rhinitis. 
As we have already mentioned early, intervention is crucial for interrupt atopic 
march and preventing allergies.
It is very well known for almost 20 years that Lactobacillus rhamnosus GG 
strain 1 × 106 cfu/g given to atopic pregnant women followed with 6 months 
of postnatal administration to infants can significantly prevent the develop-
ment of atopic dermatitis at the age of 2 years. Furthermore, protective effects 
were long lasting for two more years. On the other side, significant increase of 
atopic dermatitis prevalence has been recorded in the control group in the fol-
low up period [42]. Double blind, randomized, placebo control PandA study 
investigated the preventive effects of three strains combination Bifidobacterium 
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bifidum W23B (1 × 109 cfg/g), Bifidobacterium lactase W52 (1 × 109 cfu/g) and 
Lactococcus lactic W58 (1 × 109cfu/l). Administration of this combination to 
atopic mothers in the last 6 weeks of pregnancy and infants in the first year of life 
showed preventive effects in the first 3 months of life with the significant changes 
in intestinal microbiota and decrease in the level of IL-5 production [43]. Those 
results are in accordance with the results of Zhang meta-analysis who showed 
that prenatal and postnatal administration of probiotics may reduce the risk of 
atopic disease in families under risk of allergy and hypersensitivity reaction to 
food. According to those authors, administration of probiotics to infants born 
via cesarean section can even benefit more from probiotics [44]. Probiotics are 
also have positive impact on SCORAD reduction in placebo control study on 27 
infants with atopic dermatitis who were breast-fed and received Bifidobacterium 
lactose Bb-12 1 × 109 cfu/g and Lactobacillus GG 3 × 108 cfu/g in comparison to 
place group [45]. Majamaa and collaborators showed significant improvement of 
atopic dermatitis and reduction in fetal concentration of antitripsin-1 and TNF as 
well as up regulation of Il-10 and down regulation of pro inflammatory cytokines 
and total IgE antibodies level in infants on hypoallergenic milk formulas who 
concomitantly received Lactobacillus rhamnosus GG 5 × 108 cfu/g in comparison 
to placebo group [46]. Pessi’s study showed similar Il-10 level improvement in 
children allergic to cow milk proteins who received Lactobacillus rhamnosus GG 
2 × 1010 cfu/g pro doses [47]. Those results are controversial in terms of asthma 
and wheezing prevention. Two meta-analysis of Elazab and coauthors and Azad 
and coauthors have failed to prove positive effects of probiotics administration in 
pregnancy and postnatal on the asthma and wheezing development. Recent meta-
analysis of randomized control study of Wei and coauthors did not find enough 
results to support recommendation of probiotics for asthma prevention in infants 
[48]. In Filipovic and coauthors study, it is found that Lactobacillus rhamnosus GG 
(LGG) formulation with Zn and vitamin D3 supplementation during the postna-
tal period (in infancy and early childhood) reduce the severity of atopic dermati-
tis. Type of delivery, type of feeding breast-feeding versus adapted milk formulas 
were not found to be statistically associated with risk of atopic dermatitis [49]. 
According to European Academy for Allergy and Clinical Immunology, there is 
no official recommendation for probiotic treatment in patients with food allergy 
[50]. Overall probiotics are proven to have positive effects in primary prevention 
of allergies even prenatal. According to the results from several studies probiotics 
have both local and systemic effects. They act locally on the intestinal tract via 
promoting immune tolerance. Systemically, they act antiinflammatory reducing 
Th17 response and stimulating TLR and Th1 immune response [51, 52].
6. Conclusion
According to the epidemiological data, allergic diseases have been increasing in 
the last decades, despite a great variety of effective treatment available. Standard 
pharmacological treatment of allergies is only symptomatic without the capabil-
ity to change the natural course of allergic disease. Immunotherapy is the only 
treatment with the immunomodulatory effects. The second option is probiotics 
that are not only capable to prevent atopic march but also to prevent the devel-
opment of allergic disease prenatal. Despite a great number of placebo control 
randomized studies and meta-analysis, we are still looking for the best probiotic 
and adequate dose for each level of intervention: prenatal, early postnatal as 
well as for different manifestation of allergic diseases (atopic dermatitis, food 
allergies, asthma, and allergic rhinitis).
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